Show simple item record

Interleukin-27 Is a Potential Rescue Therapy for Acute Severe Colitis Through Interleukin-10–Dependent, T-Cell–Independent Attenuation of Colonic Mucosal Innate Immune Responses

dc.contributor.authorMcLean, Mairi H.
dc.contributor.authorAndrews, Caroline
dc.contributor.authorHanson, Miranda L.
dc.contributor.authorBaseler, Walter A.
dc.contributor.authorAnver, Miriam R.
dc.contributor.authorSenkevitch, Emilee
dc.contributor.authorStaniszewska , Aleksandra K.
dc.contributor.authorDavies, Luke C.
dc.contributor.authorHixon, Julie
dc.contributor.authorLi, Wenqeng
dc.contributor.authorShen, Wei
dc.contributor.authorSteidler, Lothar
dc.contributor.authorDurum, Scott K.
dc.date.accessioned2018-10-08T23:07:06Z
dc.date.available2018-10-08T23:07:06Z
dc.date.issued2017-11
dc.identifier.citationMcLean , M H , Andrews , C , Hanson , M L , Baseler , W A , Anver , M R , Senkevitch , E , Staniszewska , A K , Davies , L C , Hixon , J , Li , W , Shen , W , Steidler , L & Durum , S K 2017 , ' Interleukin-27 Is a Potential Rescue Therapy for Acute Severe Colitis Through Interleukin-10–Dependent, T-Cell–Independent Attenuation of Colonic Mucosal Innate Immune Responses ' , Inflammatory Bowel Diseases , vol. 23 , no. 11 , pp. 1983-1995 . https://doi.org/10.1097/MIB.0000000000001274en
dc.identifier.issn1078-0998
dc.identifier.otherPURE: 105451832
dc.identifier.otherPURE UUID: 6723d161-08fe-4ef8-a02a-da01fb10c1bc
dc.identifier.otherPubMed: 29019857
dc.identifier.otherScopus: 85040722980
dc.identifier.otherORCID: /0000-0002-7443-2653/work/76974181
dc.identifier.urihttp://hdl.handle.net/2164/11227
dc.descriptionThis work was supported in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, as well as a fellowship funded by Crohn’s and Colitis Foundation of America (MHM) and a grant from the Broad Medical Research Foundation. This project has been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E (MRA). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.en
dc.format.extent12
dc.language.isoeng
dc.relation.ispartofInflammatory Bowel Diseasesen
dc.rightshttps://creativecommons.org/licenses/by-nc/4.0/en
dc.subjectinterleukin-27en
dc.subjectcytokineen
dc.subjectIBDen
dc.subjectcolitisen
dc.subjectR Medicine (General)en
dc.subject.lccR1en
dc.titleInterleukin-27 Is a Potential Rescue Therapy for Acute Severe Colitis Through Interleukin-10–Dependent, T-Cell–Independent Attenuation of Colonic Mucosal Innate Immune Responsesen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPostprinten
dc.identifier.doihttps://doi.org/10.1097/MIB.0000000000001274
dc.date.embargoedUntil2018-10-09
dc.identifier.vol23en
dc.identifier.iss11en


Files in this item

Thumbnail
Name:
M_McLean_manuscript_accepted_I ...
Size:
1.452Mb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record